Literature DB >> 1629193

The protein-protein complex between pp60v-src and hsp90 is stabilized by molybdate, vanadate, tungstate, and an endogenous cytosolic metal.

K A Hutchison1, L F Stancato, R Jove, W B Pratt.   

Abstract

In a recent study demonstrating the cell-free reconstitution of the pp60v-src-hsp90 complex, we found that the tyrosine kinase-hsp90 complex is stabilized by molybdate (Hutchison, K. A., Brott, B. K., De Leon, J. H., Perdew, G. H., Jove, R., and Pratt, W. B. (1992) J. Biol. Chem. 267, 2902-2908). In this paper, we examine in detail the stabilization of this protein-protein interaction by transition metal oxyanions. The pp60v-src-hsp90 complex is stabilized by sodium molybdate with the same concentration dependence as the glucocorticoid receptor-hsp90 complex. As with the steroid receptor heterocomplexes, vanadate and tungstate also stabilize the pp60v-src-hsp90 interaction. Passage of cytosol through a Chelex-100 metal-chelating resin destabilizes the native pp60v-src-hsp90 complex, suggesting that the complex is normally stabilized by an endogenous metal factor. Readdition of either the heat-stable components of cytosol or a partially purified endogenous metal factor stabilizes the metal-depleted complex. Molybdate also stabilizes the presence of p50, a known hsp90-associated protein, in the pp60v-src heterocomplex. Given the identical effects of transition metal oxyanions on both pp60v-src- and steroid receptor-hsp90 complexes and the lack of any sequence homology between pp60v-src and the receptors, it seems very likely that it is the common component, hsp90, that contains the site of the metal interaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629193

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  A Chemical Biology Approach to the Chaperome in Cancer-HSP90 and Beyond.

Authors:  Tony Taldone; Tai Wang; Anna Rodina; Naga Vara Kishore Pillarsetty; Chander S Digwal; Sahil Sharma; Pengrong Yan; Suhasini Joshi; Piyusha P Pagare; Alexander Bolaender; Gail J Roboz; Monica L Guzman; Gabriela Chiosis
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-04-01       Impact factor: 10.005

Review 2.  Chaperome heterogeneity and its implications for cancer study and treatment.

Authors:  Tai Wang; Anna Rodina; Mark P Dunphy; Adriana Corben; Shanu Modi; Monica L Guzman; Daniel T Gewirth; Gabriela Chiosis
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

Review 3.  Adapting to stress - chaperome networks in cancer.

Authors:  Suhasini Joshi; Tai Wang; Thaís L S Araujo; Sahil Sharma; Jeffrey L Brodsky; Gabriela Chiosis
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

Review 4.  Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity.

Authors:  L Neckers; T W Schulte; E Mimnaugh
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

Review 5.  The penalty of stress - Epichaperomes negatively reshaping the brain in neurodegenerative disorders.

Authors:  Stephen D Ginsberg; Suhasini Joshi; Sahil Sharma; Gianny Guzman; Tai Wang; Ottavio Arancio; Gabriela Chiosis
Journal:  J Neurochem       Date:  2021-10-31       Impact factor: 5.372

6.  Hsp90 regulates the phosphorylation and activity of serum- and glucocorticoid-regulated kinase-1.

Authors:  Larissa Belova; Deanna R Brickley; Betty Ky; Sanjay K Sharma; Suzanne D Conzen
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

7.  The carboxy-terminal region of mammalian HSP90 is required for its dimerization and function in vivo.

Authors:  Y Minami; Y Kimura; H Kawasaki; K Suzuki; I Yahara
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

8.  Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.

Authors:  L Whitesell; E G Mimnaugh; B De Costa; C E Myers; L M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.